Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs NFC Indonesia Tbk. (NFCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs NFC Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while NFC Indonesia Tbk. trades at Rp1,585 (market cap 1T, 130.9K 24h volume). The key difference: NFC Indonesia Tbk. is far larger — about 3.2× Diagnos Laboratorium Utama Tbk.'s market cap, and NFC Indonesia Tbk. is more actively traded (130.9K versus 41.7K). Which is the better fit depends on your goals.
| DGNS | NFCX | |
|---|---|---|
Market Cap | 316.25B | 1T |
Volume | 41.7K | 130.9K |
Lot | 417 | 1.31K |
Turnover | 9.66M | 211.1M |
Average Price | 231.65 | 1,612.71 |
Value | 9.66M | 211.1M |
Indicative Equilibrium Price | 230 | 1,585 |
Indicative Equilibrium Volume | 2.4K | 2 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About NFC Indonesia Tbk.
PT NFC Indonesia Tbk (the Company) was established based on Notarial Deed No. 14 of Rose Takarina, S.H. dated August 26, 2013.
Read more on NFCX →
